Post-earnings recap
Reported
Wed, Jul 20, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an EPS that exceeded expectations, but the stock reacted negatively, declining by 0.93%. The lack of revenue data and management commentary may have contributed to investor uncertainty. Overall, the earnings report reflects mixed signals for the company moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.12 | N/A | +0.63% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—